6:17 PM
 | 
Sep 28, 2012
 |  BC Extra  |  Company News

Japan approves Eylea for wet AMD

Japan's Ministry of Health, Labor and Welfare (MHLW) approved an application from Bayer AG (Xetra:BAYN) for Eylea aflibercept to treat wet age-related macular degeneration (AMD)....

Read the full 114 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >